Jack Donald Hardcastle

Jack Donald Hardcastle's AcademicInfluence.com Rankings

Medical

#2844

World Rank

#3285

Historical Rank

Gastroenterology

#63

World Rank

#65

Historical Rank

Epidemiology

#542

World Rank

#565

Historical Rank

medical Degrees

Jack Donald Hardcastle

Philosophy

#8153

World Rank

#11479

Historical Rank

Logic

#5183

World Rank

#6562

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Jack Donald Hardcastle's Degrees

Doctorate Medicine Stanford University

Why Is Jack Donald Hardcastle Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jack Donald Hardcastle's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Randomised controlled trial of faecal-occult-blood screening for colorectal cancer (1989) (2752)
Measurement of gastrointestinal pH profiles in normal ambulant human subjects. (1988) (1088)
A classification of fistula‐in‐ano (1976) (741)
A classification of fistula-in-ano. (1976) (696)
The Syndrome of the Descending Perineum (1966) (348)
Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial (2002) (302)
Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up (2011) (283)
Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. (1992) (283)
Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme. (1993) (281)
The influence of tumour cell DNA abnormalities on survival in colorectal cancer (1985) (276)
RADIOIMMUNODETECTION OF HUMAN COLORECTAL CANCERS BY AN ANTI-TUMOUR MONOCLONAL ANTIBODY (1982) (198)
Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models. (1995) (181)
Study of large bowel peristalsis. (1968) (133)
A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy (2000) (117)
The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer (1999) (117)
Gastrimmune raises antibodies that neutralize amidated and glycine-extended gastrin-17 and inhibit the growth of colon cancer. (1996) (111)
Colorectal cancer, screening and survival: the influence of socio-economic deprivation. (2003) (98)
Ambulatory monitoring of oesophageal pH in reflux oesophagitis using a portable radiotelemetry system. (1982) (98)
Faecal calprotectin levels in a high risk population for colorectal neoplasia (2000) (93)
Bile reflux in columnar-lined Barrett's oesophagus. (1993) (86)
Faecal occult blood screening for colorectal cancer: is it cost-effective? (1998) (85)
Immunohistochemical localization of Y hapten and the structurally related H type‐2 blood‐group antigen on large‐bowel tumours and normal adult tissues (1984) (82)
Colorectal adenomas and diet: a case-control study of subjects participating in the Nottingham faecal occult blood screening programme. (1993) (77)
The action of sennosides and related compounds on human colon and rectum 1 (1970) (76)
Clinical outcome of colorectal cancer patients treated with human monoclonal anti‐idiotypic antibody (1994) (76)
Effect of histamine on the growth of human gastrointestinal tumours: reversal by cimetidine. (1993) (75)
Antitumor immune response and interleukin 2 production induced in colorectal cancer patients by immunization with human monoclonal anti-idiotypic antibody. (1991) (74)
Gastrointestinal intraluminal pH in normal subjects and those with colorectal adenoma or carcinoma. (1990) (64)
Psychiatric morbidity and screening for colorectal cancer (2002) (63)
Colorectal adenomas and energy intake, body size and physical activity: a case-control study of subjects participating in the Nottingham faecal occult blood screening programme. (1993) (62)
The results of 1115 patients with colorectal cancer treated over an 8-year period in a single hospital. (1985) (62)
Screening for colorectal cancer reduces emergency admissions. (1998) (60)
Flexible fiberoptic sigmoidoscopy and double-contrast barium-enema examination in the identification of adenomas and carcinoma of the colon (1983) (58)
Results of surgical treatment of squamous cell carcinoma of the anal canal and anal margin seen at St. Mark's Hospital 1928-66. (1968) (55)
Can albendazole reduce the risk of implantation of spilled protoscoleces? An animal study. (1986) (54)
A comparison of methods for increasing compliance within a general practitioner based screening project for colorectal cancer and the effect on practitioner workload. (1988) (54)
Enhanced cell-mediated tumor killing in patients immunized with human monoclonal antiidiotypic antibody 105AD7. (1994) (53)
HEART-RATES OF SURGEONS DURING OPERATIONS AND OTHER CLINICAL ACTIVITIES AND THEIR MODIFICATION BY OXPRENOLOL (1978) (52)
Physical factors in the stimulation of calonic peristalsis (1970) (51)
A study of anal incontinence and some principles of surgical treatment. (1970) (51)
Epidemiological study of asymptomatic inflammatory bowel disease: the identification of cases during a screening programme for colorectal cancer. (1989) (48)
Flow cytometric analysis of the DNA content of gastric cancer. (1987) (48)
Haemoccult screening for colorectal cancer: the effect of dietary restriction on compliance. (1994) (47)
Association of antigen expression and DNA ploidy in human colorectal tumors. (1986) (46)
CLINICAL AND ECONOMIC CONSEQUENCES OF WOUND SEPSIS AFTER APPENDICECTOMY AND THEIR MODIFICATION BY METRONIDAZOLE OR POVIDONE IODINE (1981) (45)
Five‐year prospective study of DNA tumor ploidy and colorectal cancer survival (1995) (44)
Quantitation of MHC antigen expression on colorectal tumours and its association with tumour progression. (1987) (43)
Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer (2001) (43)
Imaging of primary and metastatic colorectal cancer using an 111In‐labelled antitumour monoclonal antibody (791T/36) (1985) (41)
Ki‐ras MUTATIONS IN ADENOMAS: A CHARACTERISTIC OF CANCER‐BEARING COLORECTAL MUCOSA (1996) (41)
Endoscopic screening of relatives of patients with colorectal cancer (1998) (40)
The management of acute sigmoid volvulus in Nottingham. (1994) (39)
The influence of tumour cell DNA content on survival in colorectal cancer: a detailed analysis. (1990) (38)
Colorectal cancer screening and quality of life (1994) (37)
Therapeutic effect of the gastrin receptor antagonist, CR2093 on gastrointestinal tumour cell growth. (1992) (36)
Chemical and immunological testing for faecel occult blood: a comparison of two tests in symptomatic patients. (1992) (36)
Interval cancers in a randomized controlled trial of screening for colorectal cancer using a faecal occult blood test. (1999) (36)
The hospital costs of diagnostic procedures for colorectal cancer. (1991) (35)
Anti‐gastrin antibodies raised by gastrimmune inhibit growth of the human colorectal tumour AP5 (1995) (35)
Faecal occult blood testing and colonoscopy in the surveillance of subjects at high risk of colorectal neoplasia (1995) (35)
The cost of screening for colorectal cancer. (1991) (34)
Antigenicity of newly established colorectal carcinoma cell lines. (1986) (34)
AN IMMUNOFLUORESCENT TEST FOR FAECAL OCCULT BLOOD (1981) (34)
Gastric cancer--delay in diagnosis and its causes. (1987) (33)
Screening of average-risk individuals for colorectal cancer. WHO Collaborating Centre for the Prevention of Colorectal Cancer. (1990) (33)
Expression of CCKB/gastrin receptor isoforms in gastro‐intestinal tumour cells (1998) (33)
Role of upper gastrointestinal investigations in a screening study for colorectal neoplasia. (1990) (33)
Evaluation of the Plain Abdominal X-ray in the Acute Abdomen (1985) (32)
Two phase III trials of tauromustine (TCNU) in advanced colorectal cancer. (1995) (32)
Screening and the costs of treating colorectal cancer. (1993) (31)
Inhibition of gastrin-stimulated growth of gastrointestinal tumour cells by octreotide and the gastrin/cholecystokinin receptor antagonists, proglumide and lorglumide. (1992) (31)
Intragastric pH monitoring in acute upper gastrointestinal bleeding and the effect of intravenous cimetidine and ranitidine (1987) (31)
SUBCUTICULAR SUTURING AFTER APPENDICECTOMY (1977) (30)
High prevalence of undetected ulcerative colitis: data from the Nottingham fecal occult blood screening trial (2002) (30)
Blood transfusion and survival in colorectal cancer (1994) (30)
A prospective evaluation of the effect of tumor cell DNA content on recurrence in colorectal cancer (1991) (29)
Alkaline gastro-oesophageal reflux: dual probe pH monitoring. (1995) (29)
An evaluation of flexible fibreoptic sigmoidoscopy. (1981) (29)
The effect of vagotomy on the human gastrooesophageal sphincter. (1968) (29)
Pre‐clinical evaluation of the Gastrimmune immunogen alone and in combination with 5‐fluorouracil/leucovorin in a rat colorectal cancer model (1998) (28)
Effects of Neostigmine and Atropine on Motor Activity of Ileum, Colon, and Rectum of Anaesthetized Subjects (1970) (28)
Localisation of human osteosarcoma by antitumour monoclonal antibody. (1983) (28)
A hepatic invasive human colorectal xenograft model. (1993) (25)
The descending perineum syndrome. (1969) (25)
Effects of neostigmine and atropine on motor activity of ileum, colon, and rectum of anaesthetized subjects. (1971) (25)
Taurolidine peritoneal lavage as prophylaxis against infection after elective colorectal surgery (1994) (24)
Antibodies raised by gastrimmune inhibit the spontaneous metastasis of a human colorectal tumour, AP5LV. (1999) (24)
Increased activation of lymphocytes infiltrating primary colorectal cancers following immunisation with the anti-idiotypic monoclonal antibody 105AD7 (1999) (24)
Effect of gastrointestinal hormones and synthetic analogues on the growth of pancreatic cancer (1995) (23)
Cost-effective screening strategies for colorectal cancer. (1992) (23)
Effects of inhalation anaesthetic agents on the electrical and mechanical activity of the rat duodenum. (1982) (22)
Imaging of bone tumors using a monoclonal antibody raised against human osteosarcoma (1986) (22)
Calculation of sample size in trials of screening for early diagnosis of disease. (1987) (22)
Failure of CA19-9 to detect asymptomatic colorectal carcinoma. (1991) (21)
24-hour intragastric pH: continuous monitoring or nasogastric aspiration? (1986) (21)
Screening and the costs of treating colorectal cancer: some preliminary results. (1989) (21)
Pseudoachalasia of the Cardia: A Review (1988) (20)
Assessment of proliferation of squamous, Barrett's and gastric mucosa in patients with columnar lined Barrett's oesophagus. (1992) (20)
The effect of calcium supplements on rectal mucosal proliferation. (1995) (19)
Intraoperative testing of anastomotic integrity after stapled anterior resection for cancer. (1990) (19)
Out‐patient treatment of haemorrhoids with bipolar diathermy coagulation (1987) (18)
How often is a positive faecal occult blood test the result of coeliac disease? (2003) (18)
Screening for colorectal cancer: A critical review (1989) (17)
Isolated Organ Perfusion (1973) (16)
A comparison of an anti‐gastrin antibody and cytotoxic drugs in the therapy of human gastric ascites in SCID mice (1999) (16)
Oestrogen and progesterone receptors in gastrointestinal cancer cell lines. (1996) (16)
Effect of subject age on costs of screening for colorectal cancer. (1992) (16)
Cost savings in mass population screening for colorectal cancer resulting from the early detection and excision of adenomas. (1992) (16)
Histopathological assessment of bleeding from polyps of the colon and rectum. (1989) (16)
Screening for colorectal cancer (1986) (15)
Early Diagnosis of Colorectal Cancer: A Review (1984) (15)
A method for long-term recording of intestinal mechanical and electrical activity in the unrestrained rat. (1981) (15)
A trial of glucagon in the treatment of painful biliary tract disease (1982) (14)
Sensitivity of newly established colorectal cell lines to cytotoxic drugs and monoclonal antibody drug conjugates. (1987) (14)
Occult blood screening. (1985) (14)
Faecal occult blood screening for colorectal cancer at Nottingham: details of the verification process (2000) (14)
National survey of use of the Angelchik antireflux prosthesis. (1987) (14)
The identification of high and low risk groups for colorectal cancer using rectal mucosal crypt cell production rate (CCPR). (1993) (14)
Is dietary restriction always necessary in Haemoccult screening for colorectal neoplasia? (1993) (13)
Rehydration of guaiac-based faecal occult blood tests in mass screening for colorectal cancer. An economic perspective. (1991) (13)
Effect of Retesting with Dietary Restriction in Haemoccult Screening for Colorectal Cancer (1995) (13)
Congenital hypertrophy of the retinal pigment epithelium and mandibular osteomata as markers in familial colorectal cancer. (1994) (13)
Wheat fibre, lactulose and rectal mucosal proliferation in individuals with a family history of colorectal cancer (1994) (13)
The liver in shock (1967) (13)
Hartmann's Procedure: An Appraisal (1993) (13)
Differential expression of the lewis Y antigen defined by monoclonal antibody C14/1/46/10 in colonic polyps (1989) (13)
Immunolocalization of the murine monoclonal antibody, 791T/36 within primary human colorectal carcinomas and identification of the target antigen. (1984) (13)
FLEXIBLE SIGMOIDOSCOPY AS OUTPATIENT PROCEDURE (1983) (12)
Does β‐blockade affect surgical performance?. A double blind trial of oxprenolol (1980) (12)
The effect of calcium supplements on rectal mucosal proliferation (1995) (12)
Gastric cancer: a controlled trial of adjuvant chemotherapy following gastrectomy. (1981) (12)
Trends in Incidence and Mortality (1993) (12)
Individuals with a strong family history of colorectal cancer demonstrate abnormal rectal mucosal proliferation (1993) (12)
THE ACTION OF PORCINE GLUCAGON ON THE MOTILITY OF THE CANINE DUODENUM AND JEJUNUM (1982) (11)
The action of glucagon and commonly used antispasmodics and analgesics on the canine ureter (1983) (11)
Is an immunological faecal occult blood test better than Haemoccult? A cost-benefit study. (1995) (11)
Chemical and immunological testing for faecal occult blood in screening subjects at risk of familial colorectal cancer. (1997) (10)
Screening high-risk groups for colorectal neoplasia. (1996) (10)
Asymptomatic Colorectal Neoplasia and Fecal Characteristics (2002) (10)
A portable radiotelemetry receiver for ambulatory monitoring. (1982) (10)
Renal colic: A diagnostic and therapeutic review (1999) (10)
Summary of a working party on the surveillance of premalignant lesions. (1994) (10)
Effect of glucagon on ureteric peristalsis in man, pig, rabbit and rat. (1984) (9)
Tumour associated products in colonic lavage fluid. (1982) (9)
False-negative results of Hemoccult test in colorectal cancer (1981) (8)
Gastric acid suppression using anti-gastrin-17 antibodies produced by a gastrin immunogen, gastrimmune, in an in vivo pig model (1995) (7)
Screening for gastric carcinoma in coal miners. (1993) (7)
Surgical emergencies and manpower. (1984) (7)
Does Exercise Affect the Migrating Motor Complex in Man (1984) (7)
The effect of ritodrine and glucagon on the acutely obstructed canine ureter (1986) (6)
The liver in shock. A comparison of some techniques used currently in therapy (1968) (6)
Should we be screening for colorectal cancer? (1998) (6)
The mechanism by which senna glycosides and related compounds stimulate peristalsis in the human colon. (1970) (6)
Serum thymidine kinase in colorectal neoplasia. (1995) (6)
Haemorrhage from idiopathic annular ulcers of the small intestine. (1986) (6)
Screening an asymptomatic population for colorectal cancer. (1989) (6)
Screening for Colorectal Cancer in the United Kingdom (1986) (5)
The effect of various drugs on canine ureteric peristalsis (1986) (5)
Isolated organ perfusion for physiologic studies (2005) (5)
Fecal α1-antitrypsin detection of colorectal neoplasia (1995) (5)
Monoclonal antibody 791T/36 for tumor detection and therapy for metastases. (1983) (5)
Screening for colorectal cancer. (1985) (5)
Antibodies targeting the amino terminal portion of the human CCKB/gastrin receptor inhibit the liver invasion of a human colonic tumour (1998) (4)
Fecal alpha 1-antitrypsin detection of colorectal neoplasia. An evaluation using HemoQuant. (1995) (4)
Surgical emergencies and manpower. (1984) (4)
Malignant retroperitoneal sarcoma: a review of 32 cases. (1982) (4)
The identification of an electrically silent zone at the ileocaecocolic junction ( Abstract ) (1978) (4)
Colorectal cancer. Early diagnosis and detection. (1982) (4)
Imaging of primary and metastatic colorectal carcinoma with monoclonal antibody 791T/36 and the therapeutic potential of antibody-drug conjugates. (1987) (4)
Changes in anal sphincter tone at induction of anaesthesia. (1988) (4)
The Localisation of an Anti-Tumour Monoclonal Antibody (791T/36) in Gastro-Intestinal Tumours (1985) (4)
Recent studies of colonic and rectal motor action (1970) (4)
Delayed caecal perforation following flexible fibre‐optic sigmoidoscopy (1984) (4)
Accumulation of cytolytic T cells during 105AD7 antiidiotypic therapy in advanced colorectal cancer patients (1995) (4)
Early Diagnosis and Detection (1982) (4)
DNA content of rectal mucosa and rectal mucosal proliferation in individuals at high risk of colorectal cancer. (1994) (3)
Screening for colorectal neoplasia. (1987) (3)
Progastrin and glycine extended gastrin-17 are overexpressed in pernicious anaemia patients (1998) (3)
The effect of glucagon on the canine duodenum and small intestine [proceedings]. (1978) (3)
Cathepsin D in Breast Cancer: A Tissue Marker Associated with Metastasis (1992) (3)
An objective long-term evaluation of the Angelchik antireflux prosthesis. (1991) (3)
Design and therapeutic evaluation of monoclonal antibody 791 t 36 methotrexate conjugates (1986) (3)
Radiotherapy for palliation of residual and recurrent rectal cancer. (1988) (3)
Effect of gastrin neutralization on the progression of the adenoma: Carcinoma sequence in the Min mouse model of familial adenomatous polyposis (1998) (3)
The myoelectrical activity of the isolated perfused canine stomach. (1972) (3)
Retesting positive results in screening for colorectal cancer: a marginal analysis (1991) (3)
A study of the effect of colotomy and mucosal field changes in experimental colon cancer. (1980) (3)
Cell kinetics of the in vitro metaphase arrest technique and the clinical applications (1993) (3)
Direct mucosal targeting of colonic receptors by prokinetic drugs in an experimental model. (1999) (2)
Abnormal Gastrointestinal Motility in Diabetics and after Vagotomy (1984) (2)
The place of research in surgical training. (1989) (2)
Piperacillin in colorectal surgery. (1985) (2)
Neoplasms: diagnosis and screening (1988) (2)
The effect of onapristone, a progesterone antagonist, on the growth of human gastrointestinal cancer xenografts. (1997) (2)
The prospects for mass population screening in colorectal cancer. (1989) (2)
Immunoscintigraphy of colorectal carcinoma with monoclonal antibody 791T/36. (1984) (2)
POLYGLYCOLIC ACID AS SUTURE MATERIAL (1978) (2)
Faecal occult blood screening of first degree relatives of patients with colorectal cancer (1986) (1)
Analysis of ambulatory colonic mobility records using a BBC (B) microcomputer (1986) (1)
Hemoccult test and colorectal cancer. (1990) (1)
Screening for colorectal cancer--the Nottingham experience. (1987) (1)
OCCULT BLOOD TESTS (1989) (1)
Interactions between oestradiol and danazol on the growth of gastrointestinal tumour cells. (1993) (1)
Action of sennosides and related compounds on the human colon. (1971) (1)
Treatment of Recurrent Disease (1993) (1)
Screening for colorectal cancer. (1992) (1)
Double-blind randomised trial of 105AD7 vaccine (1997) (1)
Is it acute cholecystitis? (1986) (1)
Neoplasms: screening and diagnosis (1986) (1)
A Short-Term Radiotelemetric Provocation Test for the Diagnosis of Gastroesophageal Reflux Disease (1988) (1)
Chapter Twenty-one – Anal Continence (1969) (1)
Theinfluence oftumourcell DNA content onsurvival incolorectal cancer:adetailed analysis (1990) (1)
The use of age, symptoms and faecal occult blood (FOB) testing in the prediction of colorectal neoplasia (2000) (1)
Contents, Vol. 33, 1986 (1986) (0)
How Frequent is Colorectal Cancer (1993) (0)
Triple Radiotelemetric Pill Study of Postoperative Ileus in Man (1987) (0)
Epidemiological study ofasymptomatic inflammatory boweldisease: theidentification ofcasesduring a screening programme forcolorectal cancer (1989) (0)
Call and recall for screening (1989) (0)
Epidemiology and Aetiology of Colorectal Cancer (1993) (0)
How often is a positive faecal occult blood (FOB) test the result of coeliac disease (CD) (2000) (0)
A Comparison of an Immunological and a Chemical Faecal Occult Blood Test in Symptomatic Patients (1992) (0)
Measurementofgastrointestinal pHprofiles innormal ambulant humansubjects (2011) (0)
A technique of perfusion of the isolated canine stomach. (1970) (0)
Follow-up of patients with colorectal cancer after surgery (1980) (0)
Anal Cancer [Abridged] (1968) (0)
Submucosal transanal resection of rectal adenomas. (1993) (0)
BBC microcomputers in population screening (1986) (0)
Effect ofsubject age on costsofscreening for colorectal cancer (1992) (0)
Follow-up After Treatment of Carcinoma (1993) (0)
Colorectal disease. An introduction for surgeons and physicians. James P. S. Thomson, R. J. Nicholls and Christopher B. Williams. 250 × 190 mm. Pp. 381 + xv. Illustrated. 1981. London: Heinemann. £20·00 (1982) (0)
Taurolidine peritoneal lavage as prophylaxis against postoperative infection in colorectal surgery (1994) (0)
Screening for asymptomatic bowel cancer in general practice (1984) (0)
The isolated perfused canine stomach-duodenum preparation. (1969) (0)
Dose beta-blockade affect surgical performance? a double blind trial of oxprenolol. (1980) (0)
Why is symptomatic gastoesophageal reflux a rarity in Chinese (1990) (0)
Occult blood screening. (1985) (0)
93rd annual convention podium and poster abstracts (1994) (0)
Theeffect ofvagotomy on thehuman gastrooesophageal sphincter (1968) (0)
Screening for colorectal neoplasia: Introduction * (1991) (0)
Pathology of Colorectal Cancer (1993) (0)
Monoclonal antibody immunoscintigraphy for the detection of gastrointestinal tumours (1984) (0)
A study of large bowel peristalsis in man. (1969) (0)
The prognostic value of the monoclonal antibody (D5) detected protein, p29, in primary colorectal carcinoma. (1991) (0)
Gastrointestinal tumour cells by Octreotide and the GastrinKholecystokinin Receptor Antagonists, Proglumide and Lorglumide (1992) (0)
Physical factors inthestimulation of colonic peristalsis (1970) (0)
Comparative effect of the gastrin receptor (GR) antagonists, CR2093 and L-365,260 on the growth of gastrointestinal (GI) tumour xenografts (1991) (0)
Seventeenth Sir Peter Freyer memorial lecture and surgical symposium (1994) (0)
COLONOSCOPY OR FLEXIBLE SIGMOIDOSCOPY (1984) (0)
Gastrointestinal intraluminal pHinnormal sub jects andthose withcolorectal adenoma orcarcinoma (1990) (0)
The use of laparoscopy in surgical diagnosis. (1976) (0)
Colorectal neoplasia: Screening average risk individuals. (1991) (0)
The myoelectrical activity of the isolated perfused canine stomach nand duodenum. (1970) (0)
The effect of drugs on the electrical and mechanical activity of the isolated perfused canine stomach. (1971) (0)
Irish society of Gastroenterology joint meeting with midland gastroenterology society (1985) (0)
Abstracts from papers and posters presented (2004) (0)
Imaging of Bone and Soft Tissue Tumors Using an Antitumor Monoclonal Antibody (1986) (0)
Antigenicity ofnewlyestablished colorectal carcinoma cell (1986) (0)
Some gastro-intestinal effects of the gastrin-like decapeptide caerulein. (1969) (0)
Subject Index, Vol. 33, 1986 (1986) (0)
Complex Fistula-in-Ano: Aetiology, Management and Functional Results (1992) (0)
Effect of vagotomy and partial gastrectomy on gastro-oesophageal sphincter pressures. (1967) (0)
Combination chemotherapy in breast cancer: response rate and attempts to predict response. (1979) (0)
Inhibition of gastric cancer by anti-gastrin antibodies raised by gastrimmune (1995) (0)

This paper list is powered by the following services:

Jack Donald Hardcastle's Academic­Influence.com Rankings

Jack Donald Hardcastle's Degrees

Why Is Jack Donald Hardcastle Influential?

Jack Donald Hardcastle's Published Works

Published Works

Jack Donald Hardcastle's AcademicInfluence.com Rankings